rationale for olaparib in advanced ovarian cancer
Published 6 years ago • 89 plays • Length 2:48Download video MP4
Download video MP3
Similar videos
-
4:17
case 2: olaparib in brca-mutated ovarian cancer
-
1:04
olaparib maintenance therapy in ovarian cancer
-
6:18
value of olaparib in brca-mutated advanced ovarian cancer
-
2:18
parp inhibition in recurrent ovarian cancer
-
4:31
maintenance therapy for advanced ovarian cancer
-
0:55
a study of olaparib and cediranib in ovarian cancer
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
11:22
olaparib in ovarian cancer
-
1:11
solo3 highlights toxicities with olaparib in ovarian cancer
-
6:03
olaparib maintenance for recurrent ovarian cancer
-
1:12
data demonstrate efficacy of 3 parp inhibitors in ovarian cancer
-
1:50
results for maintenance olaparib in brca-mutated platinum-sensitive ovarian cancer
-
3:28
implications of paola-1 in advanced ovarian cancer
-
5:11
defining rucaparib’s value in recurrent ovarian cancer
-
6:43
sequencing parp inhibitors in advanced ovarian cancer
-
10:34
solo1: maintenance olaparib in advanced brca ovarian cancer
-
0:50
challenges with targeted therapies in ovarian cancer
-
3:58
solo-1: practice changing data on olaparib for ovarian cancer
-
57:11
personalizing advanced ovarian cancer treatment with parp inhibitors and novel approaches